Preventive Approach Using Venlafaxine

Clinical trial NCT05875610 · UNKNOWN

Trial details

NCT number: NCT05875610
Sponsor: Mit Ghamr Oncology Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Neuropathy Due to Chemotherapy

Start date: 2023-05-01
Primary completion: 2023-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.